Form 4: ICU Medical Inc. Director David F. Hoffmeister Reports Stock Transactions
SEC Form 4 Filing
Director David F. Hoffmeister reports acquisition and disposal of ICU Medical Inc. stock and restricted stock units.
Summary
- On May 15, 2024, David F. Hoffmeister, a director of ICU Medical Inc., reported transactions involving the company's stock.
- Hoffmeister acquired 948 shares of common stock through the vesting of restricted stock units (RSUs).
- He also disposed of 948 shares of common stock.
- Following these transactions, Hoffmeister directly owns 3,027 shares of ICU Medical Inc. common stock.
- He also acquired 1,723 restricted stock units that vest on the anniversary of the award date or the following annual stockholder meeting, whichever comes first.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of stock transactions by a company director, with no inherent positive or negative implications.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities in the company's stock.
Stakeholder Impact
- The transactions provide transparency to shareholders regarding insider activity.
Key Dates
| Date | Description |
|---|---|
| 05/15/2024 | Date of stock transactions and Form 4 filing. |
| 05/15/2025 | Expiration date for some of the Restricted Stock Units. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.